Eiger BioPharmaceuticals, Inc.
PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR

Last updated:

Abstract:

Lonafarnib and ritonavir, or a pharmaceutically acceptable salt thereof, are used in combination to treat HDV infection. In one aspect, amorphous co-precipitates comprising lonafarnib, ritonavir, and a co-polymer are provided.

Status:
Application
Type:

Utility

Filling date:

19 Oct 2020

Issue date:

1 Apr 2021